Sertralin (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sertralin" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

72nih.gov

4^th place

8^th place

51doi.org

2^nd place

5^th place

17semanticscholar.org

11^th place

51^st place

9archive.org

6^th place

9^th place

3drugs.com

399^th place

169^th place

3fda.gov

447^th place

409^th place

2books.google.com

3^rd place

11^th place

2wikidata.org

43^rd place

1^st place

1termania.net

low place

34^th place

1in.gov.br

3,151^st place

low place

1web.archive.org

1^st place

2^nd place

1unl.edu

1,708^th place

3,526^th place

1exlibrisgroup.com

9,042^nd place

low place

1worldcat.org

5^th place

10^th place

1handle.net

102^nd place

416^th place

1kcl.ac.uk

3,833^rd place

1,619^th place

1psu.edu

207^th place

192^nd place

1maastrichtuniversity.nl

low place

8,489^th place

1mhra.gov.uk

low place

1cf.ac.uk

low place

1unc.edu

1,538^th place

1,142^nd place

archive.org

Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM (Januar 2006). »The utility of in vitro cytochrome P450 inhibition data in the prediction of drug–drug interactions«. The Journal of Pharmacology and Experimental Therapeutics. 316 (1): 336–348. doi:10.1124/jpet.105.093229. PMID 16192315. S2CID 12975686.
Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M (Oktober 2015). »Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial«. JAMA Psychiatry. 72 (10): 1037–1044. doi:10.1001/jamapsychiatry.2015.1472. PMC 4811029. PMID 26351969.
Papakostas GI, Fava M (Oktober 2006). »A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder«. Canadian Journal of Psychiatry. 51 (12): 783–790. doi:10.1177/070674370605101208. PMID 17168253.
Maina G, Albert U, Salvi V, Bogetto F (Oktober 2004). »Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors«. The Journal of Clinical Psychiatry. 65 (10): 1365–1371. doi:10.4088/JCP.v65n1011. PMID 15491240.
Siepmann M, Grossmann J, Mück-Weymann M, Kirch W (Julij 2003). »Effects of sertraline on autonomic and cognitive functions in healthy volunteers«. Psychopharmacology. 168 (3): 293–298. doi:10.1007/s00213-003-1448-4. PMID 12692706. S2CID 19178740.
Gorenstein C, de Carvalho SC, Artes R, Moreno RA, Marcourakis T (Marec 2006). »Cognitive performance in depressed patients after chronic use of antidepressants«. Psychopharmacology. 185 (1): 84–92. doi:10.1007/s00213-005-0274-2. PMID 16485140. S2CID 594353.
Friedman RA (Oktober 2014). »Antidepressants' black-box warning--10 years later«. The New England Journal of Medicine. 371 (18): 1666–8. doi:10.1056/NEJMp1408480. PMID 25354101.
Cusack B, Nelson A, Richelson E (Maj 1994). »Binding of antidepressants to human brain receptors: focus on newer generation compounds«. Psychopharmacology. 114 (4): 559–565. doi:10.1007/bf02244985. PMID 7855217. S2CID 21236268.
Richelson E (Maj 2001). »Pharmacology of antidepressants«. Mayo Clinic Proceedings. 76 (5): 511–527. doi:10.4065/76.5.511. PMID 11357798.

books.google.com

Hubbard JR, Martin PR (2001). Substance Abuse in the Mentally and Physically Disabled. CRC Press. str. 26. ISBN 9780824744977.
Hemmings HC, Egan TD (2012). Pharmacology and Physiology for Anesthesia E-Book: Foundations and Clinical Application. Elsevier Health Sciences. str. 183–. ISBN 978-1-4557-3793-2.

cf.ac.uk

orca.cf.ac.uk

McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, Green L, Gregoire A, Howard LM, Jones I, Khalifeh H, Lingford-Hughes A, McDonald E, Micali N, Pariante CM, Peters L, Roberts A, Smith NC, Taylor D, Wieck A, Yates LM, Young AH (Maj 2017). »British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017« (PDF). J Psychopharmacol. 31 (5): 519–552. doi:10.1177/0269881117699361. PMID 28440103. S2CID 3335470.

doi.org

Obach RS, Cox LM, Tremaine LM (Februar 2005). »Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study«. Drug Metabolism and Disposition. 33 (2): 262–70. doi:10.1124/dmd.104.002428. PMID 15547048. S2CID 7254643.
Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM (Januar 2006). »The utility of in vitro cytochrome P450 inhibition data in the prediction of drug–drug interactions«. The Journal of Pharmacology and Experimental Therapeutics. 316 (1): 336–348. doi:10.1124/jpet.105.093229. PMID 16192315. S2CID 12975686.
DeVane CL, Liston HL, Markowitz JS (2002). »Clinical pharmacokinetics of sertraline«. Clin Pharmacokinet. 41 (15): 1247–1266. doi:10.2165/00003088-200241150-00002. PMID 12452737. S2CID 28720641.
Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, van Ommeren M, de Jong J, Seedat S, Chen H, Bisson JI (Februar 2015). »Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis«. Br J Psychiatry. 206 (2): 93–100. doi:10.1192/bjp.bp.114.148551. PMID 25644881.
Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW (september 2016). »Psychotherapy Versus Pharmacotherapy for Posttraumatic Stress Disorder: Systemic Review and Meta-Analyses to Determine First-Line Treatments«. Depression and Anxiety. 33 (9): 792–806. doi:10.1002/da.22511. PMID 27126398. S2CID 20190202.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M (Oktober 2015). »Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial«. JAMA Psychiatry. 72 (10): 1037–1044. doi:10.1001/jamapsychiatry.2015.1472. PMC 4811029. PMID 26351969.
Gao SY, Wu QJ, Sun C, Zhang TN, Shen ZQ, Liu CX, Gong TT, Xu X, Ji C, Huang DH, Chang Q, Zhao YH (november 2018). »Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births«. BMC Med. 16 (1): 205. doi:10.1186/s12916-018-1193-5. PMC 6231277. PMID 30415641.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E (Marec 2021). »A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants«. Drug Saf. 44 (3): 291–312. doi:10.1007/s40264-020-01027-x. ISSN 0114-5916. PMID 33354752. S2CID 229357583.
Sheehan DV, Kamijima K (Marec 2009). »An evidence-based review of the clinical use of sertraline in mood and anxiety disorders«. Int Clin Psychopharmacol. 24 (2): 43–60. doi:10.1097/yic.0b013e3282f4b616. PMID 21456103.
Zuckerbrot RA, Cheung A, Jensen PS, Stein RE, Laraque D (Marec 2018). »Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management«. Pediatrics. 141 (3). doi:10.1542/peds.2017-4081. PMID 29483200. S2CID 3591358.
MacQueen G, Born L, Steiner M (2001). »The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders«. CNS Drug Reviews. 7 (1): 1–24. doi:10.1111/j.1527-3458.2001.tb00188.x. PMC 6741657. PMID 11420570.
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C (Februar 2009). »Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis«. Lancet. 373 (9665): 746–758. doi:10.1016/S0140-6736(09)60046-5. PMID 19185342. S2CID 35858125.; Predloga:Lay source
Papakostas GI, Fava M (Oktober 2006). »A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder«. Canadian Journal of Psychiatry. 51 (12): 783–790. doi:10.1177/070674370605101208. PMID 17168253.
Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA (december 1997). »Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients«. The Journal of Clinical Psychiatry. 58 (12): 532–537. doi:10.4088/JCP.v58n1204. PMID 9448656.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Nemeroff CB (2007). »The burden of severe depression: a review of diagnostic challenges and treatment alternatives«. J Psychiatr Res. 41 (3–4): 189–206. doi:10.1016/j.jpsychires.2006.05.008. PMID 16870212.
For the review, see:Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS (september 2005). »Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder«. Annals of Internal Medicine. 143 (6): 415–426. doi:10.7326/0003-4819-143-6-200509200-00006. PMID 16172440. S2CID 10321621.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C (april 2010). »Sertraline versus other antidepressive agents for depression«. The Cochrane Database of Systematic Reviews (4): CD006117. doi:10.1002/14651858.CD006117.pub4. PMC 4163971. PMID 20393946.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R (Maj 2015). »Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines«. J Psychopharmacol. 29 (5): 459–525. doi:10.1177/0269881115581093. PMID 25969470. S2CID 8142581.
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ (Oktober 2002). »World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders«. World J Biol Psychiatry. 3 (4): 171–99. doi:10.3109/15622970209150621. PMID 12516310.
Sanchez C, Reines EH, Montgomery SA (Julij 2014). »A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?«. International Clinical Psychopharmacology. 29 (4): 185–196. doi:10.1097/YIC.0000000000000023. PMC 4047306. PMID 24424469.
Fava M, Judge R, Hoog SL, Nilsson ME, Koke SC (november 2000). »Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment«. The Journal of Clinical Psychiatry. 61 (11): 863–867. doi:10.4088/JCP.v61n1109. PMID 11105740.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Maina G, Albert U, Salvi V, Bogetto F (Oktober 2004). »Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors«. The Journal of Clinical Psychiatry. 65 (10): 1365–1371. doi:10.4088/JCP.v65n1011. PMID 15491240.
Schmitt JA, Kruizinga MJ, Riedel WJ (september 2001). »Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors«. Journal of Psychopharmacology. 15 (3): 173–179. doi:10.1177/026988110101500304. PMID 11565624. S2CID 26017110.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Siepmann M, Grossmann J, Mück-Weymann M, Kirch W (Julij 2003). »Effects of sertraline on autonomic and cognitive functions in healthy volunteers«. Psychopharmacology. 168 (3): 293–298. doi:10.1007/s00213-003-1448-4. PMID 12692706. S2CID 19178740.
Gorenstein C, de Carvalho SC, Artes R, Moreno RA, Marcourakis T (Marec 2006). »Cognitive performance in depressed patients after chronic use of antidepressants«. Psychopharmacology. 185 (1): 84–92. doi:10.1007/s00213-005-0274-2. PMID 16485140. S2CID 594353.
Günther T, Holtkamp K, Jolles J, Herpertz-Dahlmann B, Konrad K (Avgust 2005). »The influence of sertraline on attention and verbal memory in children and adolescents with anxiety disorders«. Journal of Child and Adolescent Psychopharmacology. 15 (4): 608–618. CiteSeerX 10.1.1.536.6334. doi:10.1089/cap.2005.15.608. PMID 16190792.
Schmitt JA, Ramaekers JG, Kruizinga MJ, van Boxtel MP, Vuurman EF, Riedel WJ (september 2002). »Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man«. Journal of Psychopharmacology. 16 (3): 207–214. doi:10.1177/026988110201600303. PMID 12236626. S2CID 25351919.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Renoir T (2013). »Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved«. Front Pharmacol. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418.
Fava GA, Gatti A, Belaise C, Guidi J, Offidani E (2015). »Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review«. Psychother Psychosom. 84 (2): 72–81. doi:10.1159/000370338. PMID 25721705.
Revet A, Montastruc F, Roussin A, Raynaud JP, Lapeyre-Mestre M, Nguyen TT (Junij 2020). »Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database«. BMC Psychiatry. 20 (1): 308. doi:10.1186/s12888-020-02711-z. PMC 7298955. PMID 32546134.
Garrett AR, Hawley JS (april 2018). »SSRI-associated bruxism: A systematic review of published case reports«. Neurology. Clinical Practice. 8 (2): 135–141. doi:10.1212/CPJ.0000000000000433. PMC 5914744. PMID 29708207.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Shor J, Churrango G, Hosseini N, Marshall C (2019). »Management of microscopic colitis: challenges and solutions«. Clin Exp Gastroenterol. 12: 111–120. doi:10.2147/CEG.S165047. PMC 6398419. PMID 30881078.
Croft H, Settle E, Houser T, Batey SR, Donahue RM, Ascher JA (april 1999). »A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline«. Clinical Therapeutics. 21 (4): 643–58. doi:10.1016/S0149-2918(00)88317-4. PMID 10363731.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Bala A, Nguyen HM, Hellstrom WJ (Januar 2018). »Post-SSRI Sexual Dysfunction: A Literature Review«. Sexual Medicine Reviews. 6 (1): 29–34. doi:10.1016/j.sxmr.2017.07.002. PMID 28778697.
Fornaro M, Anastasia A, Valchera A, Carano A, Orsolini L, Vellante F, in sod. (2019). »The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?«. Frontiers in Psychiatry. 10: 294. doi:10.3389/fpsyt.2019.00294. PMC 6510161. PMID 31130881.
Friedman RA (Oktober 2014). »Antidepressants' black-box warning--10 years later«. The New England Journal of Medicine. 371 (18): 1666–8. doi:10.1056/NEJMp1408480. PMID 25354101.
Stone MB (Oktober 2014). »The FDA warning on antidepressants and suicidality--why the controversy?«. The New England Journal of Medicine. 371 (18): 1668–71. doi:10.1056/NEJMp1411138. PMID 25354102.
Gunnell D, Saperia J, Ashby D (Februar 2005). »Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review«. BMJ. 330 (7488): 385. doi:10.1136/bmj.330.7488.385. PMC 549105. PMID 15718537.
Lattimore KA, Donn SM, Kaciroti N, Kemper AR, Neal CR, Vazquez DM (september 2005). »Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis«. Journal of Perinatology. 25 (9): 595–604. doi:10.1038/sj.jp.7211352. PMID 16015372.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, Green L, Gregoire A, Howard LM, Jones I, Khalifeh H, Lingford-Hughes A, McDonald E, Micali N, Pariante CM, Peters L, Roberts A, Smith NC, Taylor D, Wieck A, Yates LM, Young AH (Maj 2017). »British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017« (PDF). J Psychopharmacol. 31 (5): 519–552. doi:10.1177/0269881117699361. PMID 28440103. S2CID 3335470.
Tatsumi M, Groshan K, Blakely RD, Richelson E (december 1997). »Pharmacological profile of antidepressants and related compounds at human monoamine transporters«. European Journal of Pharmacology. 340 (2–3): 249–58. doi:10.1016/s0014-2999(97)01393-9. PMID 9537821.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Owens MJ, Knight DL, Nemeroff CB (september 2001). »Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine«. Biological Psychiatry. 50 (5): 345–350. doi:10.1016/s0006-3223(01)01145-3. PMID 11543737. S2CID 11247427.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Cusack B, Nelson A, Richelson E (Maj 1994). »Binding of antidepressants to human brain receptors: focus on newer generation compounds«. Psychopharmacology. 114 (4): 559–565. doi:10.1007/bf02244985. PMID 7855217. S2CID 21236268.
Proudman RG, Pupo AS, Baker JG (Avgust 2020). »The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors«. Pharmacol Res Perspect. 8 (4): e00602. doi:10.1002/prp2.602. PMC 7327383. PMID 32608144.
Stanton T, Bolden-Watson C, Cusack B, Richelson E (Junij 1993). »Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics«. Biochemical Pharmacology. 45 (11): 2352–2354. doi:10.1016/0006-2952(93)90211-e. PMID 8100134.
Albayrak Y, Hashimoto K (2017). »Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders«. Sigma Receptors: Their Role in Disease and as Therapeutic Targets. Advances in Experimental Medicine and Biology. Zv. 964. str. 153–161. doi:10.1007/978-3-319-50174-1_11. ISBN 978-3-319-50172-7. PMID 28315270.
Hindmarch I, Hashimoto K (april 2010). »Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered«. Human Psychopharmacology. 25 (3): 193–200. doi:10.1002/hup.1106. PMID 20373470. S2CID 26491662.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Carhart-Harris RL, Nutt DJ (september 2017). »Serotonin and brain function: a tale of two receptors«. Journal of Psychopharmacology. 31 (9): 1091–1120. doi:10.1177/0269881117725915. PMC 5606297. PMID 28858536.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Harmer CJ, Duman RS, Cowen PJ (Maj 2017). »How do antidepressants work? New perspectives for refining future treatment approaches«. The Lancet. Psychiatry (v angleščini). 4 (5): 409–418. doi:10.1016/S2215-0366(17)30015-9. PMC 5410405. PMID 28153641.
Richelson E (Maj 2001). »Pharmacology of antidepressants«. Mayo Clinic Proceedings. 76 (5): 511–527. doi:10.4065/76.5.511. PMID 11357798.
Hashimoto K (september 2009). »Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship«. Central Nervous System Agents in Medicinal Chemistry. 9 (3): 197–204. doi:10.2174/1871524910909030197. PMID 20021354.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

drugs.com

»Sertraline (Zoloft) Use During Pregnancy«. Drugs.com. 4. maj 2020. Pridobljeno 17. maja 2020.
»Sertraline international«. Drugs.com. Pridobljeno 11. maja 2015.
»Sertraline Hydrochloride«. Drugs.com. The American Society of Health-System Pharmacists. Pridobljeno 8. januarja 2018.

exlibrisgroup.com

unisa.alma.exlibrisgroup.com

De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E (Marec 2021). »A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants«. Drug Saf. 44 (3): 291–312. doi:10.1007/s40264-020-01027-x. ISSN 0114-5916. PMID 33354752. S2CID 229357583.

fda.gov

Levenson M, Holland C. »Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)«. FDA. Pridobljeno 11. julija 2008.
Pfizer Inc. (30. november 2006). »Memorandum from Pfizer Global Pharmaceuticals Re: DOCKET: 2006N-0414 –"Suicidality data from adult antidepressant trials" Background package for December 13 Advisory Committee« (PDF). FDA DOCKET 2006N-0414. FDA. Pridobljeno 11. julija 2008.

accessdata.fda.gov

Sertraline FDA Label Zadnja posodobitev: maj 2014

handle.net

hdl.handle.net

Svetovna zdravstvena organizacija (2021). World Health Organization model list of essential medicines: 22nd list (2021). Ženeva: Svetovna zdravstvena organizacija. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

in.gov.br

Anvisa (31. marec 2023). »RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial« [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (v portugalščini). Diário Oficial da União (objavljeno 4. april 2023). Arhivirano iz spletišča dne 3. avgusta 2023. Pridobljeno 16. avgusta 2023.

kcl.ac.uk

kclpure.kcl.ac.uk

Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R (Maj 2015). »Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines«. J Psychopharmacol. 29 (5): 459–525. doi:10.1177/0269881115581093. PMID 25969470. S2CID 8142581.

maastrichtuniversity.nl

cris.maastrichtuniversity.nl

Schmitt JA, Ramaekers JG, Kruizinga MJ, van Boxtel MP, Vuurman EF, Riedel WJ (september 2002). »Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man«. Journal of Psychopharmacology. 16 (3): 207–214. doi:10.1177/026988110201600303. PMID 12236626. S2CID 25351919.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

mhra.gov.uk

»Report of the CSM expert working group on the safety of selective serotonin reuptake inhibitor antidepressants« (PDF). MHRA. december 2004. Pridobljeno 11. julija 2008.{{navedi splet}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

nih.gov

pubmed.ncbi.nlm.nih.gov

Obach RS, Cox LM, Tremaine LM (Februar 2005). »Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study«. Drug Metabolism and Disposition. 33 (2): 262–70. doi:10.1124/dmd.104.002428. PMID 15547048. S2CID 7254643.
Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM (Januar 2006). »The utility of in vitro cytochrome P450 inhibition data in the prediction of drug–drug interactions«. The Journal of Pharmacology and Experimental Therapeutics. 316 (1): 336–348. doi:10.1124/jpet.105.093229. PMID 16192315. S2CID 12975686.
DeVane CL, Liston HL, Markowitz JS (2002). »Clinical pharmacokinetics of sertraline«. Clin Pharmacokinet. 41 (15): 1247–1266. doi:10.2165/00003088-200241150-00002. PMID 12452737. S2CID 28720641.
Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, van Ommeren M, de Jong J, Seedat S, Chen H, Bisson JI (Februar 2015). »Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis«. Br J Psychiatry. 206 (2): 93–100. doi:10.1192/bjp.bp.114.148551. PMID 25644881.
Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW (september 2016). »Psychotherapy Versus Pharmacotherapy for Posttraumatic Stress Disorder: Systemic Review and Meta-Analyses to Determine First-Line Treatments«. Depression and Anxiety. 33 (9): 792–806. doi:10.1002/da.22511. PMID 27126398. S2CID 20190202.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M (Oktober 2015). »Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial«. JAMA Psychiatry. 72 (10): 1037–1044. doi:10.1001/jamapsychiatry.2015.1472. PMC 4811029. PMID 26351969.
Gao SY, Wu QJ, Sun C, Zhang TN, Shen ZQ, Liu CX, Gong TT, Xu X, Ji C, Huang DH, Chang Q, Zhao YH (november 2018). »Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births«. BMC Med. 16 (1): 205. doi:10.1186/s12916-018-1193-5. PMC 6231277. PMID 30415641.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E (Marec 2021). »A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants«. Drug Saf. 44 (3): 291–312. doi:10.1007/s40264-020-01027-x. ISSN 0114-5916. PMID 33354752. S2CID 229357583.
Sheehan DV, Kamijima K (Marec 2009). »An evidence-based review of the clinical use of sertraline in mood and anxiety disorders«. Int Clin Psychopharmacol. 24 (2): 43–60. doi:10.1097/yic.0b013e3282f4b616. PMID 21456103.
Zuckerbrot RA, Cheung A, Jensen PS, Stein RE, Laraque D (Marec 2018). »Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management«. Pediatrics. 141 (3). doi:10.1542/peds.2017-4081. PMID 29483200. S2CID 3591358.
MacQueen G, Born L, Steiner M (2001). »The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders«. CNS Drug Reviews. 7 (1): 1–24. doi:10.1111/j.1527-3458.2001.tb00188.x. PMC 6741657. PMID 11420570.
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C (Februar 2009). »Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis«. Lancet. 373 (9665): 746–758. doi:10.1016/S0140-6736(09)60046-5. PMID 19185342. S2CID 35858125.; Predloga:Lay source
Papakostas GI, Fava M (Oktober 2006). »A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder«. Canadian Journal of Psychiatry. 51 (12): 783–790. doi:10.1177/070674370605101208. PMID 17168253.
Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS (1996). »Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction«. The Journal of Clinical Psychiatry. 57. 57 (Suppl 2): 53–62. PMID 8626364.
Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA (december 1997). »Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients«. The Journal of Clinical Psychiatry. 58 (12): 532–537. doi:10.4088/JCP.v58n1204. PMID 9448656.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Nemeroff CB (2007). »The burden of severe depression: a review of diagnostic challenges and treatment alternatives«. J Psychiatr Res. 41 (3–4): 189–206. doi:10.1016/j.jpsychires.2006.05.008. PMID 16870212.
For the review, see:Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS (september 2005). »Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder«. Annals of Internal Medicine. 143 (6): 415–426. doi:10.7326/0003-4819-143-6-200509200-00006. PMID 16172440. S2CID 10321621.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C (april 2010). »Sertraline versus other antidepressive agents for depression«. The Cochrane Database of Systematic Reviews (4): CD006117. doi:10.1002/14651858.CD006117.pub4. PMC 4163971. PMID 20393946.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R (Maj 2015). »Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines«. J Psychopharmacol. 29 (5): 459–525. doi:10.1177/0269881115581093. PMID 25969470. S2CID 8142581.
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ (Oktober 2002). »World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders«. World J Biol Psychiatry. 3 (4): 171–99. doi:10.3109/15622970209150621. PMID 12516310.
Sanchez C, Reines EH, Montgomery SA (Julij 2014). »A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?«. International Clinical Psychopharmacology. 29 (4): 185–196. doi:10.1097/YIC.0000000000000023. PMC 4047306. PMID 24424469.
Fava M, Judge R, Hoog SL, Nilsson ME, Koke SC (november 2000). »Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment«. The Journal of Clinical Psychiatry. 61 (11): 863–867. doi:10.4088/JCP.v61n1109. PMID 11105740.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Maina G, Albert U, Salvi V, Bogetto F (Oktober 2004). »Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors«. The Journal of Clinical Psychiatry. 65 (10): 1365–1371. doi:10.4088/JCP.v65n1011. PMID 15491240.
Schmitt JA, Kruizinga MJ, Riedel WJ (september 2001). »Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors«. Journal of Psychopharmacology. 15 (3): 173–179. doi:10.1177/026988110101500304. PMID 11565624. S2CID 26017110.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Siepmann M, Grossmann J, Mück-Weymann M, Kirch W (Julij 2003). »Effects of sertraline on autonomic and cognitive functions in healthy volunteers«. Psychopharmacology. 168 (3): 293–298. doi:10.1007/s00213-003-1448-4. PMID 12692706. S2CID 19178740.
Gorenstein C, de Carvalho SC, Artes R, Moreno RA, Marcourakis T (Marec 2006). »Cognitive performance in depressed patients after chronic use of antidepressants«. Psychopharmacology. 185 (1): 84–92. doi:10.1007/s00213-005-0274-2. PMID 16485140. S2CID 594353.
Günther T, Holtkamp K, Jolles J, Herpertz-Dahlmann B, Konrad K (Avgust 2005). »The influence of sertraline on attention and verbal memory in children and adolescents with anxiety disorders«. Journal of Child and Adolescent Psychopharmacology. 15 (4): 608–618. CiteSeerX 10.1.1.536.6334. doi:10.1089/cap.2005.15.608. PMID 16190792.
Borkowska A, Pilaczyńska E, Araszkiewicz A, Rybakowski J (2002). »[The effect of sertraline on cognitive functions in patients with obsessive-compulsive disorder]«. Psychiatria Polska. 36 (6 Suppl): 289–95. PMID 12647451.
Schmitt JA, Ramaekers JG, Kruizinga MJ, van Boxtel MP, Vuurman EF, Riedel WJ (september 2002). »Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man«. Journal of Psychopharmacology. 16 (3): 207–214. doi:10.1177/026988110201600303. PMID 12236626. S2CID 25351919.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Renoir T (2013). »Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved«. Front Pharmacol. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418.
Fava GA, Gatti A, Belaise C, Guidi J, Offidani E (2015). »Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review«. Psychother Psychosom. 84 (2): 72–81. doi:10.1159/000370338. PMID 25721705.
Warner CH, Bobo W, Warner C, Reid S, Rachal J (Avgust 2006). »Antidepressant discontinuation syndrome«. American Family Physician. 74 (3): 449–456. PMID 16913164.
Revet A, Montastruc F, Roussin A, Raynaud JP, Lapeyre-Mestre M, Nguyen TT (Junij 2020). »Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database«. BMC Psychiatry. 20 (1): 308. doi:10.1186/s12888-020-02711-z. PMC 7298955. PMID 32546134.
Garrett AR, Hawley JS (april 2018). »SSRI-associated bruxism: A systematic review of published case reports«. Neurology. Clinical Practice. 8 (2): 135–141. doi:10.1212/CPJ.0000000000000433. PMC 5914744. PMID 29708207.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Shor J, Churrango G, Hosseini N, Marshall C (2019). »Management of microscopic colitis: challenges and solutions«. Clin Exp Gastroenterol. 12: 111–120. doi:10.2147/CEG.S165047. PMC 6398419. PMID 30881078.
Ferguson JM (2001). »The effects of antidepressants on sexual functioning in depressed patients: a review«. The Journal of Clinical Psychiatry. 62. 62 (Suppl 3): 22–34. PMID 11229450.
Croft H, Settle E, Houser T, Batey SR, Donahue RM, Ascher JA (april 1999). »A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline«. Clinical Therapeutics. 21 (4): 643–58. doi:10.1016/S0149-2918(00)88317-4. PMID 10363731.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Bala A, Nguyen HM, Hellstrom WJ (Januar 2018). »Post-SSRI Sexual Dysfunction: A Literature Review«. Sexual Medicine Reviews. 6 (1): 29–34. doi:10.1016/j.sxmr.2017.07.002. PMID 28778697.
Fornaro M, Anastasia A, Valchera A, Carano A, Orsolini L, Vellante F, in sod. (2019). »The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?«. Frontiers in Psychiatry. 10: 294. doi:10.3389/fpsyt.2019.00294. PMC 6510161. PMID 31130881.
Friedman RA (Oktober 2014). »Antidepressants' black-box warning--10 years later«. The New England Journal of Medicine. 371 (18): 1666–8. doi:10.1056/NEJMp1408480. PMID 25354101.
Stone MB (Oktober 2014). »The FDA warning on antidepressants and suicidality--why the controversy?«. The New England Journal of Medicine. 371 (18): 1668–71. doi:10.1056/NEJMp1411138. PMID 25354102.
Gunnell D, Saperia J, Ashby D (Februar 2005). »Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review«. BMJ. 330 (7488): 385. doi:10.1136/bmj.330.7488.385. PMC 549105. PMID 15718537.
Lattimore KA, Donn SM, Kaciroti N, Kemper AR, Neal CR, Vazquez DM (september 2005). »Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis«. Journal of Perinatology. 25 (9): 595–604. doi:10.1038/sj.jp.7211352. PMID 16015372.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, Green L, Gregoire A, Howard LM, Jones I, Khalifeh H, Lingford-Hughes A, McDonald E, Micali N, Pariante CM, Peters L, Roberts A, Smith NC, Taylor D, Wieck A, Yates LM, Young AH (Maj 2017). »British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017« (PDF). J Psychopharmacol. 31 (5): 519–552. doi:10.1177/0269881117699361. PMID 28440103. S2CID 3335470.
Tatsumi M, Groshan K, Blakely RD, Richelson E (december 1997). »Pharmacological profile of antidepressants and related compounds at human monoamine transporters«. European Journal of Pharmacology. 340 (2–3): 249–58. doi:10.1016/s0014-2999(97)01393-9. PMID 9537821.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (december 1997). »Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites«. The Journal of Pharmacology and Experimental Therapeutics. 283 (3): 1305–1322. PMID 9400006.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Owens MJ, Knight DL, Nemeroff CB (september 2001). »Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine«. Biological Psychiatry. 50 (5): 345–350. doi:10.1016/s0006-3223(01)01145-3. PMID 11543737. S2CID 11247427.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Cusack B, Nelson A, Richelson E (Maj 1994). »Binding of antidepressants to human brain receptors: focus on newer generation compounds«. Psychopharmacology. 114 (4): 559–565. doi:10.1007/bf02244985. PMID 7855217. S2CID 21236268.
Proudman RG, Pupo AS, Baker JG (Avgust 2020). »The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors«. Pharmacol Res Perspect. 8 (4): e00602. doi:10.1002/prp2.602. PMC 7327383. PMID 32608144.
Stanton T, Bolden-Watson C, Cusack B, Richelson E (Junij 1993). »Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics«. Biochemical Pharmacology. 45 (11): 2352–2354. doi:10.1016/0006-2952(93)90211-e. PMID 8100134.
Albayrak Y, Hashimoto K (2017). »Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders«. Sigma Receptors: Their Role in Disease and as Therapeutic Targets. Advances in Experimental Medicine and Biology. Zv. 964. str. 153–161. doi:10.1007/978-3-319-50174-1_11. ISBN 978-3-319-50172-7. PMID 28315270.
Hindmarch I, Hashimoto K (april 2010). »Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered«. Human Psychopharmacology. 25 (3): 193–200. doi:10.1002/hup.1106. PMID 20373470. S2CID 26491662.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Carhart-Harris RL, Nutt DJ (september 2017). »Serotonin and brain function: a tale of two receptors«. Journal of Psychopharmacology. 31 (9): 1091–1120. doi:10.1177/0269881117725915. PMC 5606297. PMID 28858536.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Harmer CJ, Duman RS, Cowen PJ (Maj 2017). »How do antidepressants work? New perspectives for refining future treatment approaches«. The Lancet. Psychiatry (v angleščini). 4 (5): 409–418. doi:10.1016/S2215-0366(17)30015-9. PMC 5410405. PMID 28153641.
Richelson E (Maj 2001). »Pharmacology of antidepressants«. Mayo Clinic Proceedings. 76 (5): 511–527. doi:10.4065/76.5.511. PMID 11357798.
Hashimoto K (september 2009). »Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship«. Central Nervous System Agents in Medicinal Chemistry. 9 (3): 197–204. doi:10.2174/1871524910909030197. PMID 20021354.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

ncbi.nlm.nih.gov

Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M (Oktober 2015). »Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial«. JAMA Psychiatry. 72 (10): 1037–1044. doi:10.1001/jamapsychiatry.2015.1472. PMC 4811029. PMID 26351969.
Gao SY, Wu QJ, Sun C, Zhang TN, Shen ZQ, Liu CX, Gong TT, Xu X, Ji C, Huang DH, Chang Q, Zhao YH (november 2018). »Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births«. BMC Med. 16 (1): 205. doi:10.1186/s12916-018-1193-5. PMC 6231277. PMID 30415641.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Depression in children and young people: identifification and management: NICE Guideline (PDF). National Institute for Health and Care Excellence (NICE). 25. junij 2019.
MacQueen G, Born L, Steiner M (2001). »The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders«. CNS Drug Reviews. 7 (1): 1–24. doi:10.1111/j.1527-3458.2001.tb00188.x. PMC 6741657. PMID 11420570.
Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C (april 2010). »Sertraline versus other antidepressive agents for depression«. The Cochrane Database of Systematic Reviews (4): CD006117. doi:10.1002/14651858.CD006117.pub4. PMC 4163971. PMID 20393946.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Sanchez C, Reines EH, Montgomery SA (Julij 2014). »A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?«. International Clinical Psychopharmacology. 29 (4): 185–196. doi:10.1097/YIC.0000000000000023. PMC 4047306. PMID 24424469.
Renoir T (2013). »Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved«. Front Pharmacol. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418.
Revet A, Montastruc F, Roussin A, Raynaud JP, Lapeyre-Mestre M, Nguyen TT (Junij 2020). »Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database«. BMC Psychiatry. 20 (1): 308. doi:10.1186/s12888-020-02711-z. PMC 7298955. PMID 32546134.
Garrett AR, Hawley JS (april 2018). »SSRI-associated bruxism: A systematic review of published case reports«. Neurology. Clinical Practice. 8 (2): 135–141. doi:10.1212/CPJ.0000000000000433. PMC 5914744. PMID 29708207.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Shor J, Churrango G, Hosseini N, Marshall C (2019). »Management of microscopic colitis: challenges and solutions«. Clin Exp Gastroenterol. 12: 111–120. doi:10.2147/CEG.S165047. PMC 6398419. PMID 30881078.
Fornaro M, Anastasia A, Valchera A, Carano A, Orsolini L, Vellante F, in sod. (2019). »The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?«. Frontiers in Psychiatry. 10: 294. doi:10.3389/fpsyt.2019.00294. PMC 6510161. PMID 31130881.
Gunnell D, Saperia J, Ashby D (Februar 2005). »Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review«. BMJ. 330 (7488): 385. doi:10.1136/bmj.330.7488.385. PMC 549105. PMID 15718537.
Proudman RG, Pupo AS, Baker JG (Avgust 2020). »The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors«. Pharmacol Res Perspect. 8 (4): e00602. doi:10.1002/prp2.602. PMC 7327383. PMID 32608144.
Carhart-Harris RL, Nutt DJ (september 2017). »Serotonin and brain function: a tale of two receptors«. Journal of Psychopharmacology. 31 (9): 1091–1120. doi:10.1177/0269881117725915. PMC 5606297. PMID 28858536.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Harmer CJ, Duman RS, Cowen PJ (Maj 2017). »How do antidepressants work? New perspectives for refining future treatment approaches«. The Lancet. Psychiatry (v angleščini). 4 (5): 409–418. doi:10.1016/S2215-0366(17)30015-9. PMC 5410405. PMID 28153641.

dailymed.nlm.nih.gov

»DailyMed - ZOLOFT- sertraline hydrochloride tablet, film coated ZOLOFT- sertraline hydrochloride solution, concentrate«.

psu.edu

citeseerx.ist.psu.edu

Günther T, Holtkamp K, Jolles J, Herpertz-Dahlmann B, Konrad K (Avgust 2005). »The influence of sertraline on attention and verbal memory in children and adolescents with anxiety disorders«. Journal of Child and Adolescent Psychopharmacology. 15 (4): 608–618. CiteSeerX 10.1.1.536.6334. doi:10.1089/cap.2005.15.608. PMID 16190792.

semanticscholar.org

api.semanticscholar.org

Obach RS, Cox LM, Tremaine LM (Februar 2005). »Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study«. Drug Metabolism and Disposition. 33 (2): 262–70. doi:10.1124/dmd.104.002428. PMID 15547048. S2CID 7254643.
Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM (Januar 2006). »The utility of in vitro cytochrome P450 inhibition data in the prediction of drug–drug interactions«. The Journal of Pharmacology and Experimental Therapeutics. 316 (1): 336–348. doi:10.1124/jpet.105.093229. PMID 16192315. S2CID 12975686.
DeVane CL, Liston HL, Markowitz JS (2002). »Clinical pharmacokinetics of sertraline«. Clin Pharmacokinet. 41 (15): 1247–1266. doi:10.2165/00003088-200241150-00002. PMID 12452737. S2CID 28720641.
Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW (september 2016). »Psychotherapy Versus Pharmacotherapy for Posttraumatic Stress Disorder: Systemic Review and Meta-Analyses to Determine First-Line Treatments«. Depression and Anxiety. 33 (9): 792–806. doi:10.1002/da.22511. PMID 27126398. S2CID 20190202.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E (Marec 2021). »A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants«. Drug Saf. 44 (3): 291–312. doi:10.1007/s40264-020-01027-x. ISSN 0114-5916. PMID 33354752. S2CID 229357583.
Zuckerbrot RA, Cheung A, Jensen PS, Stein RE, Laraque D (Marec 2018). »Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management«. Pediatrics. 141 (3). doi:10.1542/peds.2017-4081. PMID 29483200. S2CID 3591358.
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C (Februar 2009). »Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis«. Lancet. 373 (9665): 746–758. doi:10.1016/S0140-6736(09)60046-5. PMID 19185342. S2CID 35858125.; Predloga:Lay source
For the review, see:Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS (september 2005). »Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder«. Annals of Internal Medicine. 143 (6): 415–426. doi:10.7326/0003-4819-143-6-200509200-00006. PMID 16172440. S2CID 10321621.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R (Maj 2015). »Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines«. J Psychopharmacol. 29 (5): 459–525. doi:10.1177/0269881115581093. PMID 25969470. S2CID 8142581.
Schmitt JA, Kruizinga MJ, Riedel WJ (september 2001). »Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors«. Journal of Psychopharmacology. 15 (3): 173–179. doi:10.1177/026988110101500304. PMID 11565624. S2CID 26017110.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Siepmann M, Grossmann J, Mück-Weymann M, Kirch W (Julij 2003). »Effects of sertraline on autonomic and cognitive functions in healthy volunteers«. Psychopharmacology. 168 (3): 293–298. doi:10.1007/s00213-003-1448-4. PMID 12692706. S2CID 19178740.
Gorenstein C, de Carvalho SC, Artes R, Moreno RA, Marcourakis T (Marec 2006). »Cognitive performance in depressed patients after chronic use of antidepressants«. Psychopharmacology. 185 (1): 84–92. doi:10.1007/s00213-005-0274-2. PMID 16485140. S2CID 594353.
Schmitt JA, Ramaekers JG, Kruizinga MJ, van Boxtel MP, Vuurman EF, Riedel WJ (september 2002). »Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man«. Journal of Psychopharmacology. 16 (3): 207–214. doi:10.1177/026988110201600303. PMID 12236626. S2CID 25351919.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, Green L, Gregoire A, Howard LM, Jones I, Khalifeh H, Lingford-Hughes A, McDonald E, Micali N, Pariante CM, Peters L, Roberts A, Smith NC, Taylor D, Wieck A, Yates LM, Young AH (Maj 2017). »British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017« (PDF). J Psychopharmacol. 31 (5): 519–552. doi:10.1177/0269881117699361. PMID 28440103. S2CID 3335470.
Owens MJ, Knight DL, Nemeroff CB (september 2001). »Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine«. Biological Psychiatry. 50 (5): 345–350. doi:10.1016/s0006-3223(01)01145-3. PMID 11543737. S2CID 11247427.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Cusack B, Nelson A, Richelson E (Maj 1994). »Binding of antidepressants to human brain receptors: focus on newer generation compounds«. Psychopharmacology. 114 (4): 559–565. doi:10.1007/bf02244985. PMID 7855217. S2CID 21236268.
Hindmarch I, Hashimoto K (april 2010). »Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered«. Human Psychopharmacology. 25 (3): 193–200. doi:10.1002/hup.1106. PMID 20373470. S2CID 26491662.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

termania.net

https://www.termania.net/slovarji/slovenski-medicinski-slovar/5538288/sertralin?query=Sertralin&SearchIn=All, Slovenski medicinski e-slovar, vpogled: 26. 1. 2024.

unc.edu

pdsp.unc.edu

Roth BL, Driscol J. »PDSP K_i Database«. Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Pridobljeno 14. avgusta 2017.

unl.edu

digitalcommons.unl.edu

Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW (september 2016). »Psychotherapy Versus Pharmacotherapy for Posttraumatic Stress Disorder: Systemic Review and Meta-Analyses to Determine First-Line Treatments«. Depression and Anxiety. 33 (9): 792–806. doi:10.1002/da.22511. PMID 27126398. S2CID 20190202.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

web.archive.org

Anvisa (31. marec 2023). »RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial« [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (v portugalščini). Diário Oficial da União (objavljeno 4. april 2023). Arhivirano iz spletišča dne 3. avgusta 2023. Pridobljeno 16. avgusta 2023.

wikidata.org

Marc B. Stone; M. Lisa Jones (17. november 2006), Clinical review: relationship between antidepressant drugs and suicidality in adults, Uprava za hrano in zdravila, str. 1–64, Wikipodatki Q118139691
Mark S Levenson; George Rochester; Chris Holland (17. november 2006), Statistical Evaluation of Suicidality in Adults Treated with Antidepressants, Uprava za hrano in zdravila, str. 1–65, Wikipodatki Q118139771

worldcat.org

De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E (Marec 2021). »A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants«. Drug Saf. 44 (3): 291–312. doi:10.1007/s40264-020-01027-x. ISSN 0114-5916. PMID 33354752. S2CID 229357583.